Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of the Endocannabinoid System in Psychiatric Disorders: Pharmacological fMRI Study
2007-004247-30Phase 2Suspended
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dronabinol in schizophrenia, major depressive disorder (MDD), attention deficit hyperactivity disorder (ADHD) and 3 more (2 arms), sponsored by University Medical Center Utrecht. Started Oct 2007; status: suspended.
02
Drugs
dronabinol
03
Conditions
schizophreniamajor depressive disorder (MDD)attention deficit hyperactivity disorder (ADHD)obsessive compulsive disorder (OCD)substance use disorder (SUD)
Beyond the preview
Go deeper on 2007-004247-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004247-30.